Previous Close | 17.39 |
Open | 17.39 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 17.39 - 17.39 |
52 Week Range | 10.04 - 21.80 |
Volume | |
Avg. Volume | 129 |
Market Cap | 4.54B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 4.67 |
EPS (TTM) | 3.72 |
Earnings Date | May 02, 2024 |
Forward Dividend & Yield | 1.02 (5.88%) |
Ex-Dividend Date | Feb 23, 2024 |
1y Target Est | 41.80 |
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint